Pancreatic Cancer Research

ResearcherChang Gung UniversityNo recent work listed

Chun‐Nan Yeh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1455-092X; OpenAlex author ID A5090866906. Sources: OpenAlex.

Their work

Papers
10 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: 3 papers · 2019: none · 2020: none · 2021: 1 paper

Papers 10

  1. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway. Co-author DOI 10.7150/ijbs.55919↗
  2. Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center. Co-author DOI 10.1016/j.asjsur.2016.11.009↗
  3. CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery. Co-author DOI 10.21873/invivo.11411↗
  4. Surgical Margin Status of Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Radical Intent: Risk Factors for the Survival Impact of Positi… Last author DOI 10.21873/invivo.11419↗
  5. Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. Co-author DOI 10.1097/md.0000000000004191↗
  6. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells. First author DOI 10.1016/j.canlet.2014.08.019↗
  7. A novel role of the tumor size in pancreatic cancer as an ancillary factor for predicting resectability. Co-author DOI 10.4103/0973-1482.131464↗
  8. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. First author DOI 10.4161/cc.24445↗
  9. Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer. First author DOI 10.1186/1477-7819-10-77↗
  10. Vitamin d and pancreatic cancer-an update. First author DOI 10.3390/cancers3010213↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tsann‐Long Hwang · 6 shared papers, 2012–2018 · strength 0.38
  2. Kun‐Chun Chiang · 6 shared papers, 2011–2018 · strength 0.27
  3. Chih-Po Hsu · 3 shared papers, 2016–2018 · strength 0.22
  4. Shuijie Li · 1 shared paper, 2021 · strength 0.14
  5. Wen‐Kuan Huang · 1 shared paper, 2021 · strength 0.14
  6. Tai C. Chen · 3 shared papers, 2011–2014 · strength 0.11
  7. Chun‐Chi Lai · 1 shared paper, 2018 · strength 0.09
  8. Miin‐Fu Chen · 2 shared papers, 2012–2014 · strength 0.08
  9. Horng‐Heng Juang · 2 shared papers, 2013–2014 · strength 0.07
  10. Keng-Hao Liu · 1 shared paper, 2016 · strength 0.06
  11. Shih-Chun Chang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.